Reply to 'Single high dose versus repeated bone-targeted radionuclide therapy'
- PMID: 29247283
- DOI: 10.1007/s00259-017-3902-2
Reply to 'Single high dose versus repeated bone-targeted radionuclide therapy'
Comment on
-
Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival.Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):620-629. doi: 10.1007/s00259-016-3543-x. Epub 2016 Oct 21. Eur J Nucl Med Mol Imaging. 2017. PMID: 27770145 Free PMC article.
-
Single high dose versus repeated bone-targeted radionuclide therapy.Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2144-2145. doi: 10.1007/s00259-017-3815-0. Epub 2017 Aug 31. Eur J Nucl Med Mol Imaging. 2017. PMID: 28861597 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
